NCT06431347 · M.D. Anderson Cancer Center
Prospective Observational Cohort Study of Transplant and Cell Therapy Candidates and Recipients to Assess Social Determinants of Health
What this study is about
To learn more about social and financial factors that may influence outcomes of TCT treatment at MD Anderson.
View original scientific description
To learn more about social and financial factors that may influence outcomes of TCT treatment at MD Anderson.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- ≥ 18 years of age.
- Received financial clearance for TCT. Qualitative study - patients
- Patient ≥ 18 years of age who is currently cared for at MD Anderson as a TCT candidate/ recipient,
- The patient reports social and/or financial challenges impacting care delivery.
- The patient is willing to participate in a semi-structured interview. Qualitative study - caregivers
- Caregiver(s) of a patient ≥ 18 years of age who is currently cared for at MD Anderson as a TCT candidate/ recipient.
- The patient reports social and/or financial challenges impacting care delivery.
- The patient has referred the caregiver(s) to participate and provided us with permission to contact their caregiver(s).
- The caregiver(s) is (are) willing to participate in a semi-structured interview.
Exclusion criteria
- Patients - Quantitative study 1) Did not receive financial clearance for TCT Patients - Qualitative study 1\) Not impacted by social or financial challenges. Caregivers (qualitative study)
- Did not care for a patient impacted by social or financial challenges
- Were not referred to participate in the study by patient they cared for.
Where
- Houston, Texas
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Mar 16, 2026 · Source of record for eligibility and locations